Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Its clinical-stage drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator, CK-136, a novel cardiac troponin activator, reldesemtiv, a novel fast skeletal muscle troponin activator, aficamten, a novel cardiac myosin inhibitor, and CK-3772271, a novel cardiac myosin inhibitor. The company was founded by Ronald D. Vale, Lawrence S. B. Goldstein, James H. Sabry, and James A. Spudich in 1997 and is headquartered in South San Francisco, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Malik Fady Ibraham | EVP Research & Development | Jun 11 '24 | Option Exercise | 7.96 | 5,422 | 43,159 | 142,792 | Jun 11 04:22 PM | Malik Fady Ibraham | EVP Research & Development | Jun 11 '24 | Sale | 53.04 | 7,788 | 413,106 | 135,004 | Jun 11 04:22 PM | Bhanji Muna | Director | Jun 10 '24 | Sale | 52.07 | 2,000 | 104,140 | 17,631 | Jun 10 04:15 PM | Blum Robert I | President & CEO | Jun 04 '24 | Sale | 48.85 | 22,500 | 1,099,125 | 439,145 | Jun 07 04:03 PM | PARSHALL B LYNNE | Director | Jun 03 '24 | Option Exercise | 10.68 | 5,000 | 53,400 | 20,600 | Jun 04 04:30 PM | Wong Robert | VP, Chief Accounting Officer | Jun 03 '24 | Sale | 48.88 | 13,011 | 635,978 | 16,653 | Jun 03 04:33 PM | PARSHALL B LYNNE | Director | Jun 03 '24 | Sale | 48.64 | 5,000 | 243,200 | 15,600 | Jun 04 04:30 PM | Harrington Robert Arthur | Director | Jun 03 '24 | Sale | 48.64 | 1,580 | 76,851 | 15,541 | Jun 05 05:23 PM | Malik Fady Ibraham | EVP Research & Development | May 07 '24 | Option Exercise | 6.67 | 14,186 | 94,621 | 152,603 | May 07 04:37 PM | Malik Fady Ibraham | EVP Research & Development | May 07 '24 | Sale | 65.11 | 15,547 | 1,012,265 | 137,056 | May 07 04:37 PM | HENDERSON JOHN T | Director | Apr 25 '24 | Sale | 64.54 | 10,562 | 681,671 | 32,070 | Apr 25 06:54 PM | Malik Fady Ibraham | EVP Research & Development | Apr 09 '24 | Option Exercise | 6.67 | 28,605 | 190,795 | 171,172 | Apr 09 04:38 PM | Malik Fady Ibraham | EVP Research & Development | Apr 09 '24 | Sale | 74.31 | 32,605 | 2,422,918 | 138,567 | Apr 09 04:38 PM | Malik Fady Ibraham | EVP Research & Development | Mar 05 '24 | Option Exercise | 6.67 | 28,604 | 190,789 | 167,577 | Mar 05 04:05 PM | Malik Fady Ibraham | EVP Research & Development | Mar 05 '24 | Sale | 67.56 | 32,604 | 2,202,606 | 138,973 | Mar 05 04:05 PM | HENDERSON JOHN T | Director | Feb 14 '24 | Option Exercise | 4.44 | 5,000 | 22,200 | 47,632 | Feb 14 04:04 PM | HENDERSON JOHN T | Director | Feb 14 '24 | Sale | 76.48 | 5,000 | 382,400 | 42,632 | Feb 14 04:04 PM | Blum Robert I | President & CEO | Feb 13 '24 | Option Exercise | 6.67 | 12,500 | 83,375 | 454,297 | Feb 13 04:01 PM | Blum Robert I | President & CEO | Feb 13 '24 | Sale | 76.85 | 12,500 | 960,625 | 441,797 | Feb 13 04:01 PM | Malik Fady Ibraham | EVP Research & Development | Feb 06 '24 | Option Exercise | 6.67 | 28,605 | 190,795 | 175,578 | Feb 06 04:43 PM | Malik Fady Ibraham | EVP Research & Development | Feb 06 '24 | Sale | 79.30 | 32,605 | 2,585,496 | 142,973 | Feb 06 04:43 PM | Blum Robert I | President & CEO | Jan 31 '24 | Option Exercise | 6.67 | 12,500 | 83,375 | 454,297 | Feb 02 04:41 PM | Blum Robert I | President & CEO | Jan 31 '24 | Sale | 79.57 | 12,500 | 994,625 | 441,797 | Feb 02 04:41 PM | Blum Robert I | President & CEO | Jan 19 '24 | Option Exercise | 6.67 | 12,500 | 83,375 | 454,297 | Jan 22 05:19 PM | Blum Robert I | President & CEO | Jan 19 '24 | Sale | 81.42 | 12,500 | 1,017,750 | 441,797 | Jan 22 05:19 PM | HENDERSON JOHN T | Director | Jan 12 '24 | Option Exercise | 4.44 | 5,000 | 22,200 | 47,632 | Jan 12 05:20 PM | HENDERSON JOHN T | Director | Jan 12 '24 | Sale | 85.14 | 5,000 | 425,700 | 42,632 | Jan 12 05:20 PM | Malik Fady Ibraham | EVP Research & Development | Jan 04 '24 | Option Exercise | 7.96 | 11,678 | 92,957 | 162,651 | Jan 04 04:36 PM | Malik Fady Ibraham | EVP Research & Development | Jan 04 '24 | Sale | 86.98 | 15,678 | 1,363,712 | 146,973 | Jan 04 04:36 PM | Blum Robert I | President & CEO | Jan 02 '24 | Option Exercise | 6.67 | 12,500 | 83,375 | 454,297 | Jan 02 05:55 PM | Blum Robert I | President & CEO | Jan 02 '24 | Sale | 85.08 | 12,500 | 1,063,500 | 441,797 | Jan 02 05:55 PM | WIERENGA WENDALL | Director | Dec 27 '23 | Option Exercise | 4.44 | 10,000 | 44,400 | 23,653 | Dec 27 04:11 PM | WIERENGA WENDALL | Director | Dec 27 '23 | Sale | 73.60 | 10,000 | 736,000 | 18,653 | Dec 27 04:11 PM | HENDERSON JOHN T | Director | Dec 18 '23 | Option Exercise | 6.72 | 13,020 | 87,494 | 44,838 | Dec 19 04:12 PM | Blum Robert I | President & CEO | Dec 18 '23 | Option Exercise | 6.67 | 12,500 | 83,375 | 454,297 | Dec 19 04:13 PM | Blum Robert I | President & CEO | Dec 18 '23 | Sale | 36.95 | 12,500 | 461,875 | 441,797 | Dec 19 04:13 PM | HENDERSON JOHN T | Director | Dec 18 '23 | Sale | 36.34 | 2,458 | 89,324 | 42,380 | Dec 19 04:12 PM | Blum Robert I | President & CEO | Nov 30 '23 | Option Exercise | 6.67 | 12,500 | 83,375 | 453,917 | Dec 01 04:15 PM | Blum Robert I | President & CEO | Nov 30 '23 | Sale | 32.99 | 12,500 | 412,375 | 441,417 | Dec 01 04:15 PM | Blum Robert I | President & CEO | Nov 15 '23 | Option Exercise | 6.67 | 12,500 | 83,375 | 453,917 | Nov 15 05:22 PM | Blum Robert I | President & CEO | Nov 15 '23 | Sale | 34.57 | 12,500 | 432,125 | 441,417 | Nov 15 05:22 PM | Malik Fady Ibraham | EVP Research & Development | Nov 09 '23 | Sale | 35.40 | 2,500 | 88,500 | 150,664 | Nov 09 04:35 PM | Blum Robert I | President & CEO | Oct 30 '23 | Option Exercise | 6.67 | 12,500 | 83,375 | 453,917 | Oct 30 04:02 PM | Blum Robert I | President & CEO | Oct 30 '23 | Sale | 32.17 | 12,500 | 402,125 | 441,417 | Oct 30 04:02 PM | Blum Robert I | President & CEO | Oct 16 '23 | Option Exercise | 6.67 | 12,500 | 83,375 | 453,917 | Oct 16 05:57 PM | Blum Robert I | President & CEO | Oct 16 '23 | Sale | 33.70 | 12,500 | 421,250 | 441,417 | Oct 16 05:57 PM | Malik Fady Ibraham | EVP Research & Development | Oct 12 '23 | Sale | 35.89 | 2,500 | 89,725 | 153,164 | Oct 12 06:39 PM | Blum Robert I | President & CEO | Oct 06 '23 | Option Exercise | 6.67 | 12,500 | 83,375 | 453,917 | Oct 06 04:52 PM | Blum Robert I | President & CEO | Oct 06 '23 | Sale | 30.00 | 12,500 | 375,000 | 441,417 | Oct 06 04:52 PM | Malik Fady Ibraham | EVP Research & Development | Sep 14 '23 | Sale | 34.86 | 2,500 | 87,150 | 155,664 | Sep 14 04:09 PM | Blum Robert I | President & CEO | Sep 13 '23 | Option Exercise | 6.67 | 12,500 | 83,375 | 453,917 | Sep 13 04:09 PM | Blum Robert I | President & CEO | Sep 13 '23 | Sale | 34.90 | 12,500 | 436,206 | 441,417 | Sep 13 04:09 PM | Blum Robert I | President & CEO | Aug 25 '23 | Option Exercise | 7.70 | 12,500 | 96,275 | 453,917 | Aug 28 06:45 PM | Blum Robert I | President & CEO | Aug 25 '23 | Sale | 33.99 | 12,500 | 424,875 | 441,417 | Aug 28 06:45 PM | WIERENGA WENDALL | Director | Aug 21 '23 | Option Exercise | 6.72 | 6,020 | 40,454 | 24,225 | Aug 21 04:01 PM | WIERENGA WENDALL | Director | Aug 21 '23 | Sale | 32.02 | 6,020 | 192,760 | 18,205 | Aug 21 04:01 PM | Blum Robert I | President & CEO | Aug 11 '23 | Option Exercise | 9.54 | 12,500 | 119,287 | 453,125 | Aug 11 04:18 PM | Blum Robert I | President & CEO | Aug 11 '23 | Sale | 32.37 | 12,500 | 404,589 | 441,417 | Aug 11 04:18 PM | Malik Fady Ibraham | EVP Research & Development | Aug 10 '23 | Sale | 31.70 | 2,500 | 79,250 | 158,164 | Aug 10 04:14 PM | Blum Robert I | President & CEO | Aug 01 '23 | Option Exercise | 9.65 | 12,500 | 120,625 | 452,108 | Aug 01 04:57 PM | Blum Robert I | President & CEO | Aug 01 '23 | Sale | 32.63 | 12,500 | 407,856 | 441,417 | Aug 01 04:57 PM | Blum Robert I | President & CEO | Jul 13 '23 | Option Exercise | 9.65 | 12,500 | 120,625 | 453,917 | Jul 13 04:10 PM | Blum Robert I | President & CEO | Jul 13 '23 | Sale | 35.28 | 12,500 | 440,940 | 441,417 | Jul 13 04:10 PM | Malik Fady Ibraham | EVP Research & Development | Jul 13 '23 | Sale | 35.37 | 2,500 | 88,425 | 160,664 | Jul 13 04:09 PM | Bhanji Muna | Director | Jul 07 '23 | Sale | 34.12 | 2,000 | 68,235 | 14,031 | Jul 07 04:17 PM | Blum Robert I | President & CEO | Jul 03 '23 | Option Exercise | 9.65 | 12,500 | 120,625 | 453,917 | Jul 05 04:18 PM | Blum Robert I | President & CEO | Jul 03 '23 | Sale | 32.60 | 12,500 | 407,500 | 441,417 | Jul 05 04:18 PM |
|